Elmustine
依莫司汀
Report date: 2022/03/23 11:08:23
NME
Base Information
Drug NameElmustine
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAmerican Society Of Travel Advisors (Asta)
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksWikipedia